搜索临床试验以:HMG-CoA 还原酶抑制(阿托伐他汀)
总计2405个结果
-
Amgen完全的糖尿病、高脂血症、混合性血脂异常美国, 加拿大, 法国, 大韩民国, 中国, 阿根廷, 俄罗斯联邦, 哥伦比亚, 火鸡, 巴西
-
I.M. Sechenov First Moscow State Medical University完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Yonsei UniversityChong Kun Dang Pharmaceutical Corp.未知冠状动脉疾病 | 冠状动脉硬化 | 羟甲基戊二酰辅酶 A 还原酶抑制剂大韩民国
-
Shanghai Jiao Tong University School of Medicine未知
-
Ministry of Science and Technology of the People´s...未知
-
Joaquina Baranda主动,不招人
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Regina Elena Cancer Institute未知
-
PfizerDiabetes UK; Department of Health, United Kingdom完全的心绞痛,不稳定 | 脑血管意外 | 冠状动脉搭桥术 | 血运重建 | 主要冠状动脉事件英国
-
Brigham and Women's Hospital完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的心血管疾病 | 冠状动脉疾病
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de Louvain完全的
-
University of Oxford完全的
-
San Filippo Neri General HospitalAssociazione Nazionale Medici Cardiologi Ospedalieri终止
-
Yonsei University完全的